Benefits were consistent across glomerular disease subtypes, too

Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic…

Benefits were consistent across glomerular disease subtypes, too